Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity

Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity

Idiosyncratic drug hepatotoxicity represents a major problem in drug development due to inadequacy of current preclinical screening assays, but recently established rodent models utilizing bacterial LPS co-administration to induce an inflammatory background have successfully reproduced idiosyncratic...

Full description

Bibliographic Details
Main Authors: Xu, Jinghai J., Hendriks, Bart S., Cosgrove, Benjamin D., King, Bracken Matheny, Hasan, Maya A., Alexopoulos, Leonidas G., Farazi, Paraskevi A., Sorger, Peter K., Tidor, Bruce, Griffith, Linda G., Lauffenburger, Douglas A.
Other Authors: Massachusetts Institute of Technology. Biotechnology Process Engineering Center
Format: Article
Language:en_US
Published: Elsevier Ltd. 2011
Online Access:http://hdl.handle.net/1721.1/67046
https://orcid.org/0000-0002-3320-3969
https://orcid.org/0000-0002-1801-5548

Internet

http://hdl.handle.net/1721.1/67046
https://orcid.org/0000-0002-3320-3969
https://orcid.org/0000-0002-1801-5548

Similar Items